| 摘要 |
The invention provides a new pharmaceutical composition for treating cardiovascular disease, which contains the active component 2-butyl-4-chlorine-1-[2'-(1H-tetrazol-5-yl)1.1'-biphenyl-methyl]imidazole-5-carboxylic acid,1-[(isopropoxy)carbonyloxy]methyl easter dispersing in the pharmaceutically acceptable carrier materials. The said composition can be prepared to solid dosage forms e.g. powders, granules, dripping pills, micro-pills, tablets, capsules and lozenges etc. by mouth or other way e.g. sublingual administration etc. |
